Publication | Closed Access

AMG 145, a Monoclonal Antibody Against PCSK9, Facilitates Achievement of National Cholesterol Education Program–Adult Treatment Panel III Low-Density Lipoprotein Cholesterol Goals Among High-Risk Patients

Cardiovascular DiseaseMedicineImmunologyDyslipidemiaLipoprotein MetabolismFacilitates AchievementAtherosclerosisHigh-risk PatientsAmg 145